(Q45876542)

17 December 2017

title

Adenovirus-mediated apo(a)-antisense-RNA expression efficiently inhibits apo(a) synthesis in vitro and in vivo (English)

1 reference

17 December 2017

1 reference

2

1 reference

17 December 2017

author name string

Frank S

1

1 reference

17 December 2017

Strauss J

3

1 reference

17 December 2017

Hrzenjak A

4

1 reference

17 December 2017

Kostner GM

5

1 reference

17 December 2017

publication date

1 March 2001

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

425-430

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301434

exact match

0 references

cites work

The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Molecular definition of the extreme size polymorphism in apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

RNase III cleaves eukaryotic preribosomal RNA at a U3 snoRNP-dependent site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Purification and characterization of the Pac1 ribonuclease of Schizosaccharomyces pombe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Virus treatment questioned after gene therapy death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

High-capacity adenoviral vectors for gene transfer and somatic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

A new technique for the assay of infectivity of human adenovirus 5 DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Structural requirements of apo-a for the lipoprotein-a assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Lipoprotein Lp(a) and the risk for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Aspirin reduces apolipoprotein(a) (apo(a)) production in human hepatocytes by suppression of apo(a) gene transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Escherichia coli ribonuclease III cleavage sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

The role of apo-(a) kringle-IVs in the assembly of lipoprotein-(a)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301434

1 reference

17 December 2017

Dimensions Publication ID

1024807867

0 references

1 reference

17 December 2017